Dr. Elizabeth Anne Putnam, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 110 Hill Pond Ln, Statesboro, GA 30458 Phone: 912-489-3668 |
Ankle And Foot Assoc, Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1088 Bermuda Run, Suite B, Statesboro, GA 30458 Phone: 912-681-8000 Fax: 912-681-8500 |
Todd Roswell Becker, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Grady Johnson Rd, Statesboro, GA 30458 Phone: 912-681-8000 Fax: 912-681-8500 |
East Georgia Foot And Ankle Center Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1088 B Bermuda Run Road, Statesboro, GA 30458 Phone: 912-681-8000 Fax: 912-681-8500 |
Dr. Robert William Cushner, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 95 Bel Air Drive, Statesboro, GA 30461 Phone: 912-489-8727 Fax: 912-764-7882 |
Dr. Kristian Danielle Jeffress, DPM Podiatrist - Foot & Ankle Surgery Medicare: May Accept Medicare Assignments Practice Location: 110 Hill Pond Ln, Statesboro, GA 30458 Phone: 912-489-3668 Fax: 912-489-4795 |
Family Foot Care Of Statesboro Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 407 S Zetterower Ave, Statesboro, GA 30458 Phone: 912-489-3668 Fax: 912-489-4795 |
Dr. Howard M Gale, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1088 B Bermuda Run Road, Statesboro, GA 30458 Phone: 912-681-8000 Fax: 912-681-8500 |
News Archive
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that a scientific paper co-authored by Ryo Kubota, M.D., Ph.D., chairman, president and chief executive officer of Acucela, has been published in Experimental Eye Research. The paper, "Visual Cycle Modulation in Neurovascular Retinopathy" was also co-authored by scientists from Children's Hospital and Harvard Medical School in Boston and demonstrates for the first time the impact of treatment with a visual cycle modulator (VCM) on retinopathy in an immature eye.
Hitachi High-Technologies Corporation and QIAGEN N.V. have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing.
In this post in USAID's "IMPACTblog," guest blogger Joanna Breitstein, director of communications for the TB Alliance, describes an event organized by the Critical Paths to TB Drug Regimens that took place on Monday, "heralding the launch of a new clinical trial that tests tuberculosis drugs in combination."
New heart imaging technology to diagnose coronary heart disease and other heart disorders is significantly more accurate, less expensive and safer than traditional methods, according to a new study by researchers from the Intermountain Medical Center Heart Institute in Salt Lake City.
› Verified 1 days ago